Zafer EROL, Nilay DUMAN, Nilay ŞEN KORKMAZ

Host immune responses and peritumoral stromal reactions in different basal cell carcinoma subtypes: histopathological comparison of basosquamous carcinoma and high-risk and low-risk basal cell carcinoma subtypes

Background/aim: The literature does not include sufficient data on the associations between host immune responses and stromal reactions in different basal cell carcinoma (BCC) subtypes. The aim of the study was to compare host immune responses and stromal reactions between basosquamous carcinoma (BSC) and high-risk (HR) and low-risk (LR) BCC subtypes. Materials and methods: The study included 35 BSC, 40 HR-BCC, and 40 LR-BCC patients. Age, sex, lesion location, density of peritumoral/adjacent perivascular inflammation, presence of lymphoid follicle formation, and stromal reaction type were compared between groups. Results: In all 3 groups, age, sex distribution, and lesion location were similar. Overall, 70% of lesions in the LR-BCC group exhibited mild peritumoral inflammation, whereas in the BSC and HR-BCC groups dense inflammation was observed in 50% and 57.5% of lesions, respectively (P < 0.001). All lesions (100%) in the LR-BCC group had fibromyxoid stroma, whereas 61.8% and 80% of lesions in the BSC and HR-BCC groups, respectively, had desmoplastic stroma (P < 0.001). Conclusion: The BSC and HR-BCC groups were similar in terms of host immune responses and stromal reactions. Furthermore, BSC and HR-BCC were associated with dense peritumoral inflammation, adjacent perivascular inflammation, and desmoplastic stroma.

PDF

___

1. Garcia C, Poletti E, Crowson AN. Basosquamous carcinoma. J Am Acad Dermatol 2009; 60: 137143.
2. Betti R, Crosti C, Ghiozzi S, Cerri A, Moneghini L, Menni S. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas. Eur J Dermatol 2013; 23: 8386.
3. Volkenstein S, Wohlschlaeger J, Liebau J, Arens A, Lehnerdt G, Jahnke K, Neumann A. Basosquamous carcinoma--a rare but aggressive skin malignancy. J Plast Reconstr Aesthet Surg 2010; 63: e304e306.
4. Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 2006; 19: 127147.
5. Bhanja KC, Mallick SK, Sharma S, Saha R. Cutaneous basaloid squamous of the face, a rare variant: a case report. IJCRI 201 2; 3: 2023.
6. Tan SH, Chong AW, Nazarina AR, Prepageran N. Basaloid squamous cell carcinoma of the oropharynx: comparison of two cases and review of the literature. Otolaryngol Pol 2014; 68: 268270.
7. Kaur P, Mulvaney M, Carlson JA. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis. Am J Dermatopathol 2006; 28: 293307.
8. Betti R, Menni S, Radaelli G, Bombonato C, Crosti C. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas. J Dermatol 2010; 37: 611616.
9. Kaporis H, Del Rosso JQ. Peritumoral inflammation in basal cell carcinoma: fundamentals, clinical significance, and changes after topical imiquimod therapy. Cosmet Dermatol 2008; 21: 3843.
10. Kaporis HG, Guttman-Yassky E, Lowes MA, Haider AS, Fuentes-Duculan J, Darabi K, Whynot-Ertelt J, Khatcherian A, Cardinale I, Novitskaya I et al. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment. J Invest Dermatol 2007; 127: 23912398.
11. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006; 6: 295307.
12. Stary G, Bangert C, Tauber M, Strohal R, Kopp T, Stingl G. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J Exp Med 2007; 204: 14411451.
13. Lesack K, Naugler C. Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes. BMC Dermatol 2012; 12: 1.
14. Dixon AY, Lee SH, McGregor DH. Factors predictive of recurrence of basal cell carcinoma. Am J Dermatopathol 1989; 11: 222232.
15. Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer 1982; 49: 533537.
16. Bartos V, Adamicova K, Kullova M, Pec M. Comparison of histological types of primary and subsequent relapsing basal cell carcinomas of the skin. Klin Onkol 2012; 25: 262266.
17. Pieh S, Kuchar A, Novak P, Kunstfeld R, Nagel G, Steinkogler FJ. Long-term results after surgical basal cell carcinoma excision in the eyelid region. Br J Ophthalmol 1999; 83: 8588.
18. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol 2006; 1: 119150.
19. Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr Opin Genet Dev 2005; 15: 97101.
20. Reuter JA, Ortiz-Urda S, Kretz M, Garcia J, Scholl FA, Pasmooij AM, Cassarino D, Chang HY, Khavari PA. Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression. Cancer Cell 2009; 15: 477488.